4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-033001
Director bought 15,000 shares at $1.45 ($21,750)
From the SEC's structured data for this filing
Trades in this filing
ASELAGE STEVE · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-11-18 | Purchase : show line 1 in the form | +15,000 | $1.45 | $21,750 | 21,672 | D |
| Open-market purchases · 15,000 sh · avg $1.45 · $21,750 | ||||||
Loading xslF345X03/form4.xml…